An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness

被引:82
作者
Ouyang, Q
Wagner, WM
Walter, S
Müller, CA
Wikby, A
Aubert, G
Klatt, T
Stevanovic, S
Dodi, T
Pawelec, G
机构
[1] ZMF, Tuebingen Ageing & tumour Immunol Grp, Med Res Ctr, D-72072 Tubingen, Germany
[2] Sect Transplantat Immunol & Immunohematol, Tubingen, Germany
[3] Dept Immunol, Tubingen, Germany
[4] Univ Tubingen, Tubingen, Germany
[5] Jonkoping Univ, Dept Nat Sci & Biomed, Sch Hlth Sci, Jonkoping, Sweden
[6] UCL Royal Free & Univ Coll Med Sch, Anthony Nolan Res Inst, London, England
关键词
ageing; T cell; Epstein-Barr virus; EBV; tetramer; IFN-gamma;
D O I
10.1016/S0047-6374(03)00026-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this study was to provide a basis for investigating the effects of one very common environmental factor, Epstein-Barr virus (EBV), on age-related changes in the immune system. To this end, the frequency of CD8(+) T cells carrying receptors for an immunodominant EBV lytic epitope was assessed by direct staining with HLA-peptide tetrameric complexes in 19 very old (> 87 years) and 12 young (20-40 years) EBV carriers. The frequency of EBV-tetramer-positive cells within the CD8(+) subset was significantly greater in the old compared to the young group (P = 0.001). However, the frequency of EBV antigen-specific IFN-gamma producing T cells, as determined by ELISPOT, was significantly lower in the old (P = 0.001). Therefore, the absolute number of functional EBV-specific T cells in the elderly and the young was probably similar. These data suggest CD8 clonal expansions in the elderly, resulting in an accumulation of dysfunctional EBV-specific cells which possibly fill the 'immunological space' and could lead to a shrinking of the T cell repertoire for other novel antigens. This may help to explain the increased incidence and case-fatality caused by viruses and intracellular pathogens in the elderly. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 15 条
  • [1] Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells
    Albanese, Manuel
    Tagawa, Takanobu
    Bouvet, Mickael
    Maliqi, Liridona
    Lutter, Dominik
    Hoser, Jonathan
    Hastreiter, Maximilian
    Hayes, Mitch
    Sugden, Bill
    Martin, Larissa
    Moosmann, Andreas
    Hammerschmidt, Wolfgang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (42) : E6467 - E6475
  • [2] Immunophenotypic analysis of Epstein-Barr virus (EBV)infected CD8+ T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis
    Wada, Taizo
    Kurokawa, Toshiro
    Toma, Tomoko
    Shibata, Fumie
    Tone, Yumi
    Hashida, Yoko
    Kaya, Hiroyasu
    Yoshida, Takashi
    Yachie, Akihiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (01) : 72 - 75
  • [3] Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis
    Hoshino, Yo
    Nishikawa, Kazuo
    Ito, Yoshinori
    Kuzushima, Kiyotaka
    Kimura, Hiroshi
    JOURNAL OF CLINICAL VIROLOGY, 2011, 50 (03) : 244 - 246
  • [4] Computational Prediction and Identification of Epstein-Barr Virus Latent Membrane Protein 2A Antigen-Specific CD8+ T-Cell Epitopes
    Bing Wang
    Kun Yao
    Genyan Liu
    Fangyi Xie
    Feng Zhou
    Yun Chen
    Cellular & Molecular Immunology, 2009, 6 : 97 - 103
  • [5] Computational Prediction and Identification of Epstein-Barr Virus Latent Membrane Protein 2A Antigen-Specific CD8+ T-Cell Epitopes
    Wang, Bing
    Yao, Kun
    Liu, Genyan
    Xie, Fangyi
    Zhou, Feng
    Chen, Yun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2009, 6 (02) : 97 - 103
  • [6] Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro
    Gansuvd, B
    Hagihara, M
    Munkhbat, B
    Kanai, N
    Morita, N
    Munkhtuvshin, N
    Chargui, J
    Kato, S
    Hotta, T
    Tsuji, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01) : 107 - 114
  • [7] Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection
    Hislop, AD
    Annels, NE
    Gudgeon, NH
    Leese, AM
    Rickinson, AB
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) : 893 - 905
  • [8] Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8+ T cells during highly active antiretroviral therapy is associated with an increase in CD4+ T cells
    Kostense, S
    Otto, SA
    Knol, GJ
    Manting, EH
    Nanlohy, NM
    Jansen, C
    Lange, JMA
    van Oers, MHJ
    Miedema, F
    van Baarle, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 1080 - 1089
  • [9] Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells
    Subklewe, M
    Sebelin, K
    Block, A
    Meier, A
    Roukens, A
    Paludan, C
    Fonteneau, JFO
    Steinman, RM
    Münz, C
    HUMAN IMMUNOLOGY, 2005, 66 (09) : 938 - 949
  • [10] Decreased EBNA-1-specific CD8+T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma
    Fogg, Mark H.
    Wirth, Lori J.
    Posner, Marshall
    Wang, Fred
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) : 3318 - 3323